“…Fifty‐four mutations presented in the a determinant are associated with the atypical profile of simultaneous presence of HBsAg and anti‐HBs markers. Among these mutations, the G145R (glycine‐to‐arginine substitution at position 145 associated with hepatitis B vaccination and the use of HBIG) and I126S (isoleucine‐to‐serine substitution at position 126 related to chronic infection that alters the antigenicity of HBsAg, and immune escape) are the most frequently described until now [Cuestas et al, ; Lada et al, ; Lu et al, ; Mathet et al, ; Colson et al, ; Sayiner et al, ; Zhang et al, ; Velu et al, ; Jang et al, ; Hsu et al, ; Huang et al, ; van Dommelen et al, ; Wang et al, ; Chen et al, ; Liu et al, ; Hsu et al, ; Ding et al, ; Pancher et al, ; Pu et al, ; Ding et al, ; Liu et al, ].…”